Literatura
Kontakt Forum RSS
Ginekologija
Brojni znanstvenici istražuju uzroke, a drugi nastoje pronaći brzu i učinkovitu pomoć za liječenje ginekoloških oboljenja. Većina njih usmjerena je na tjelesne smetnje, dok je manje učinjeno na razjašnjenju psiholoških mehanizama povezanih s ovim tegobama.

Literatura

Vezano
Datum zadnje izmjene: 6. siječnja 2017.

Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725-36.

Evans P, Brunsell S.
Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician. 2007; 75 (10):1503-8.

Phillips JB. Quick Review: Uterine Fibroids. The Internet J Gynecol Obstet. 2002; Vol 1, Number 2.

Ferrero S, Abbamonte LH, Giordano M et al. Uterine myomas, dyspareunia, and sexual function. Fertil Steril. 2006; 86(5):1504-10.

Flake GP, Andersen J, Dixon D.
Etiology and Pathogenesis of Uterine Leiomyomas: A Review. Environ Health Perspect 2003; 111: 1037-54

Johannisson R. Zur Genetik und Pathogenese des Uterus myomatosus. Gynäkol Endokrin 2004; 2:27-32

Baird DD, Dunson DB, Hill MC et al.
High cumulative incindence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol 2003; 188: 100-7

Kaminski BT, Rzempoluch J. Evaluation of the influence od certain epidemiologic factors on development of uterine myomas. Wiad Leuk 1993; 46 (15-16): 592-6

Marshall LM, Spegelman D, Goldman MB et al.
A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 1998; 70 (3): 432-9

Colacurci N, De Franciscis P, Cobellis L et al.
Effects of hormone replacement therapy on postmenopausal uterine myoma. Maturitas 2000; 35 (2): 167-73

Hoffmann PJ, Milliken DB, Gregg LC et al
. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. Fertil Steril 2004; 82 (3): 639-49

Pollow K, Schmidt-Gollwitzer M, Boquoi E, Pollow B. Estrogen receptors in normal human myometrium and leiomyoma. J Mol Med 1977; 2 81): 61-8

Bodner K, Bodner-Adler B, Kimberger O et al. Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Fertil Steril 2004; 81 (4): 1062-6

Pollow K, Sinnecker G, Boquoi E, Pollow B.
In vitro conversion of estradiol-17beta into estrone in normal human myometrium and leiomyoma. J Clin Chem Clin Biochem 1978; 16 (9): 493-502

Levy M, Mittal K, Chiriboga L et al. Differential expression of selected gene products in uterine leiomyomata and adenomyosis. Fertil Steril. 2007; 88(1):220-3.

Pollow K, Geilfuss J, Boquoi E, Pollow B.
Estrogen and progesteron binding proteins in normal human myometrium and leiomyoma tissue. J Clin Chem Clin Biochem 1978; 16 (9): 503-11

Sadan O, van Iddekinge B, van Geldern CJ et al.
Oestrogen and progesteron receptor concentrations in leiomyoma and normal myometrium. Ann Clin Biochem 1987; 24 (pt 3): 263-7

Rein MS, Barbieri RL, Friedman AJ.
Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995; 172 (1 Pt 1): 14-8

Martel KM, Ko AC, Christman KM, Stribley JM. Apoptosis in Human Uterine Leiomyomas. Semin Reprod Med 2004; Vol 22 (2): 91-103

NICHD Press Release. Fibroid Tumors Lack Crucial Structural Protein. 2004. http://www.nih.gov/news/pr/jun2004/nichd-02.htm

Lefebvre G, Vilos G, Allaire C et al.
The management of uterine leiomyomas. J Obstet Gynaecol Can 2003; 25 (5): 396-418

Wallach EE, Vlahos NF.
Uterine myomas: an overview of development, clinical features and management. Obstet Gynecol 2004; 104 (2): 393-406

Sheiner E, Bashiri A, Levy A et al. Obstet characteristics and perinatal outcome of pregnancies with uterine leiomyomas. J Reprod Med 2004; 49 (39: 182-6

Schweppe KW. Progestins and uterine leiomyoma. Gynecol Endocrinol 1999; 13 Suppl 4: 21-4

Maruo T.
Progesterone and progesterone receptor modulator in uterine leiomyoma growth.
Gynecol Endocrinol. 2007; 23(4):186-7.

Eldar-Geva T, Healy DL, Monash IVF et al. Other medical management of uterine fibroids. Naillieres Clin Obstet Gynaecol 1998; 12 (2): 269-88

Olive DL, Lindheim SR, Pritts EA.
Non-surgical management of leiomyoma: impact on fertility. Curr Opin Obstet Gynecol 2004; 16 83): 239-43

Shaw RW. Mechanism of LHRH analogue action in uterine fibroids. Horm Res 1989; 32 suppl 1: 150-3

Golan A. GnRH analogues in the treatment of uterine fibroids. Hum Reprod 1996; Suppl 3: 33-41

Serra GB, Panetta V, Colosimo M et al. Efficacy of leuoprorelin acetate depot in symptomatic fibromatous uteri: the Italian Multicentre Trial. Clin The 1992; 14 Suppl A: 57-73

De Falco M, Pollio F, Pontillo M et al. GnRH agonists and antagonists in the preoperative therapy of uterine fibroids: literature review. Minerva Ginecol. 2006; 58(6):553-60.

Chia CC, Huang SC, Chen SS et al. Ultrasonographic evaluation of the change in uterine fibroids induced by treatment with a GnRH analog. Taiwan J Obstet Gynecol. 2006; 45(2):124-8.

Mirenna A, Fiorito A, Cavallaro A et al.
Laparoscopic hysterectomy after GnRh analogue therapy. Minerva Ginecol. 2007;59(2):107-10.

Melli MS, Farzadi L, Madarek EO. Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression. Saudi Med J. 2007; 28(3):445-50.

Ishihara H, Kitawaki J, Kado N et al. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis or leiomyomas. Fertil Steril 2003; 79 Suppl 1: 735-42

De Leo V, la Marca A, Morgante G. Short-term treatment of uterine fibromyomas with danazol. Gynecol Obstet Invest 1999; 47 (4): 258-62

De Leo V, Morgante G. Lanzetta D et al. Danazol administration after gonadotropin-releasing hormone analogue reduces rebound of uterine myomas. Hum Reprod 1997; 12 (2): 357-60

Imir AG, Lin Z, Yin P et al.
Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3/II. J Clin Endocrinol Metab. 2007; 92 (5):1979-82.

Shozu M, Murakami K, Inouue M. Aromatase and Leiomyoma of the Uterus. Sem Reprod Med 2004; Vol 22 (1): 51-60

Karaer O, Orue S, Koyuncu FM.
Aromatase inhibitors: possible future applications. Acta Obstet Gynecol Scand 2004; 83 (8): 699-706

Fiscella K, Eisinger SH, Meldrum S et al.
Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial. Obstet Gynecol. 2006; 108(6):1381-7.

Eisinger SH, Meldrum S, Fiscella K et al. Low dose mifepristone for uterine myomata. Obstet Gynecol 2003; 101 (2): 243-50

Eisinger SH, Bonfiglio T, Fiscella K. Twelwe-month safety and efficacy of low dose mifepristone for uterine myomas. J Minim Invasive Gynecol 2005; 12 (3): 227-33

Steinauer J, Pritts EA, Jackson R, Jacoby AF. Systematic review of mifepristone for the treatment of uterine leiomyomata. Obstet Gynecol 2004; 103 (6): 1331-6

Lingxia X, Taixiang W, Xiaoyan C.
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. Cochrane Database Syst Rev. 2007;(2):CD005287.

Cook JD, Walker CL. Treatment strategies for uterine leiomyoma: the role of hormonal modulation. Semin Reprod Med 2004; 22 (2): 105-11

Chabert-Buffet N, Meduri G, Bouchard P, Spitz IM. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum Reprod Update 2005; 11 (3): 293-307

Kaunitz AM. Progestin-releasing intrauterine systems and leiomyoma. Contraception. 2007; 75(6 Suppl):S130-3.

Maruo T, Ohara N, Matsuo H et al. Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas. Contraception. 2007;75(6 Suppl):S99-S103.

Jansen JT. Noncontraceptive applications of the levonorgestrel intrauterine system. Current Women’s Health Report 2002; 2:417-22

Borghese B, Chapron C. Treatment of symptomatic uterine fibroids.
N Engl J Med. 2007;356(21):2218-9

Apgar BS, Kaufman AH, George-Nwogu U, Kittendorf A. Treatment of menorrhagia. Am Fam Physician. 2007;75(12):1813-9.

Ravina JH, Bouret JM, Ciraru-Vigneron N et al. Recourse to particular arterial embolization in the treatment of some uterine leiomyoma. Bull Acad Natl Med 1997; 181: 233-43

Helmberger TK, Jakobs TF, Reiser MF.
Embolization of uterine fibroids. Abdom Imaging 2004; 29 (2): 267-77

White AM, Spies JB.
Uterine fibroid embolization. Tech Vasc Interv Radiol. 2006; 9(1):2-6.

Spies JB, Cooper JM, Worthington-Kirsch R et al. Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. Am J Obstet Gynecol 2004; 191 (1): 22-31

Siskin G. New treatments for uterine fibroids. Tech Vasc Interv Radiol. 2006;9(1):12-8.

Domenico L Jr, Siskin GP.
Uterine artery embolization and infertility. Tech Vasc Interv Radiol. 2006; 9(1):7-11.

El-Miligy M, Gordon A, Houston G.
Focal myometrial defect and partial placenta accreta in a pregnancy following bilateral uterine artery embolization. J Vasc Interv Radiol. 2007;18(6):789-91.

Gabriel-Cox K, Jacobson GF, Armstrong MA et al.
Predictors of hysterectomy after uterine artery embolization for leiomyoma. Am J Obstet Gynecol. 2007;196(6):588.e1-6.

Leslie TA, Kennedy JE.
High intensity focused ultrasound in the treatment of abdominal and gynaecological diseases. Int J Hyperthermia. 2007; 23 (2):173-82.

Mahajan NN, Gaikwad NL, Soni RN, Mahajan KN. Extracorporeal ablation of uterine fibroids with high-intensity focused ultrasound. J Ultrasound Med. 2007;26(5):702

Fennessy FM, Tempany CM, McDannold NJ et al.
Uterine leiomyomas: MR imaging-guided focused ultrasound surgery--results of different treatment protocols. Radiology. 2007; 243(3):885-93.

Arleo EK, Khilnani NM, Ng A, Min RJ. Features influencing patient selection for fibroid treatment with magnetic resonance-guided focused ultrasound. J Vasc Interv Radiol. 2007;18(5):681-5.

Peacock K, Hurst BS. Laparoscopic Myomectomy. Surg Technol Int. 2006;15:141-5.

Parker WH.
Laparoscopic myomectomy and abdominal myomectomy. Clin Obstet Gynecol. 2006; 49(4):789-97.

Indman PD.
Hysteroscopic treatment of submucous myomas. Clin Obstet Gynecol. 2006; 49(4):811-20.

Mara M, Fucikova Z, Kuzel D et al. Hysteroscopy after uterine fibroid embolization in women of fertile age. J Obstet Gynaecol Res. 2007;33 (3):316-24.

Mittapalli R, Fanning J, Flora R, Fenton BW.
Cost-effectiveness analysis of the treatment of large leiomyomas: laparoscopic assisted vaginal hysterectomy versus abdominal hysterectomy. Am J Obstet Gynecol. 2007;196(5):e19-21.

Donnez J, Squifflet J, Polet R et al. Laparoscopic myolysis. Hum Reprod Update 2000; 6: 609-13

Zupi E, Sbracia M, Marconi D, Munro MG. Myolysis of uterine fibroids: is there a role? Clin Obstet Gynecol. 2006; 49(4):821-33.

Hald K, Klow NE, Qvigstad E, Istre O.
Laparoscopic occlusion compared with embolization of uterine vessels: a randomized controlled trial. Obstet Gynecol. 2007;109(1):20-7.

Holub Z, Mara M, Eim J.
Laparoscopic uterine artery occlusion versus uterine fibroid embolization.
Int J Gynaecol Obstet. 2007; 96(1):44-5.

Vilos GA, Hollett-Caines J, Burbank F. Uterine artery occlusion: what is the evidence? Clin Obstet Gynecol. 2006; 49(4):798-810.

Jacobson GF, Shaber RE, Armstrong MA, Hung YY.
Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine leiomyoma. Am J Obstet Gynecol. 2007;196(6):601.e1-5

Khurram IM, Choudhry KS, Muhammad K, Islam N. Clinical presentation of hypothyroidism: a case control analysis. J Ayub Med Coll Abbottabad. 2003;15 (1):45-9.

Lombardo F, Gandini L, Santulli M et al. Endocrinological diagnosis in sexology. J Endocrinol Invest. 2003;26 (3 Suppl):112-4.

Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003 Jun 26;348(26):2646-55.

Poppe K, Glinoer D.
Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum Reprod Update. 2003;9(2):149-61

Il’ in V. Clinical features of mental disorders among gynecologic patients with hormonal dysfunction and hormone-dependent pathology. Zh Nevropatol Psikhiatr Im S S Korsakova. 1983; 83 (11): 1691-5

Il’ in V, Pokhil’ko V.
Comparative multidimensional analysis of the personality traits of patients with different forms of gynecologic pathology. Zh Nevropatol Psikhiatr Im S S Korsakova. 1983; 83 (12): 1836-40

Fellmlann M, Battegay R, Rauchfleisch U, Mall-Haefeli M. Comparative socioeconomic, anamnestic and psychological studies of patients with uterine myoma and uterine prolapse. Schweiz Arch Neurol Neurochir Psychiatr 1983; 132 (1): 105-15

Nicholls C, Glover L, Pistrang N. The illness experiences of women with fibroids: an exploratory qualitative study. J Psychosom Obstet Gynecol 2004; 25 (3-4): 295-304

Brekhman GI. Psychoemotional stress syndrome and uterine myoma. Akush Ginekol (Mosk) 1990; 2: 13-7

Glase R, Rice J, Sheridan J et al. Stress-related immune suppression: health implications. Brain Behav Immun 1987; 1(1):7-20

Moyad MA, Pienta KJ. Mind-body effect: insulinlike growth factor-1; clinical depression; and breast, prostate and other cancer risk – an unmeasured and masked mediator of potential significance? Urology 2002; 59 (4 Suppl 1):4-8

Brekhman GI. Psycho-electroregulation in conservative treatment of patients with uterine myoma. Akush Ginekol (Mosk) 1991; 12: 48-51

Jarosch L, Grün A. Živi što jesi. Biblijski ženski likovi kao arhetipi. Kršćanska sadašnjost, Zagreb, 2006.

Chiaffarino F, Parazzini F, La Vecchia C et al. Diet and uterine myomas. Obstet Gynecol 1999; 94 (3): 395-8

Carper J. Hrana čudesni lijek, Leo Commerce 2000.

Goldin BR, Adlercreutz H, Gorbacxh SL et al.
Estrogen excretion patterns and plasma levels in vegetarian and omniovorous women. N Engl J Med 1982; 307 (25): 1542-7

Shushan A, Ben-Bassat H, Mishani E et al. Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050. Fertil Steril. 2007; 87(1):127-35.

Schottner M, Bansser D, Spiteller G.
Interaction of lignans with sex hormone binding globulin (SHBG). Z Naturforsch 1997; 52 (11-12): 834-43

Pettit JL. Fiber. Clinician Reviews 2002; 12 (9): 71-5

Young SL, Al-Hendy A, Copland JA. Potential Nonhormonal Therapeutics for Medical Treatment of Leiomyomas. Sem Reprod Med; 2004; Vol 22 (2): 121-30

Fruscella L, Ciaglia EM, Danti M et al.
Vitamin E in the treatment of pregnancy complicatesd by uterine myoma. Minerva Ginecol 1997; 49 (4): 175-9

Atkins R. Vita-hranjiva Dr. Atkinsa. VBZ Zagreb, 1999.

Mindell E. Tajni lijekovi, Mozaik knjiga Zagreb, 1999.

Null G. Enciklopedija za žene. Prirodnim liječenjem do zdravlja, Barka Zagreb 1999.

Ankem K. Information-seeking behavior of women in their path to an innovative alternate treatment for symptomatic uterine fibroids. J Med Libr Assoc. 2007;95(2):164-72, e51-3.

Mehl-Madrona L. Complementary medicine treatment of uterine fibroids: a pil study. Altern Ther Health Med 2002; 8 (2): 34-6

Lark SM. Natural Treatment of Fibroid Tumors and Endometriosis. Keats Publishing ,Inc New Canaan. 1996.

Fugh-Berman A, Kronenberg F.
Complementary and alternative medicine (CAM) in reproductive-age women: a review of randomized controlled trials. Reprod Toxicol 2003; 17 (2): 137-52

Theiss P, Kalođera Z. Ljekovito bilje za zdravu obitelj. Natur Produkt Zagreb 2004

Kuštrak D. Farmakognozija i fitofarmacija. Golden Marketing – Tehnička knjiga. Zagreb 2005

Baird DD, Dunson DB, Hill MC et al. Association of physical activity with development of uterine leiomyoma. Am J Epidemiol. 2007; 165(2):157-63.

http://www.mendosa.com/sawpalm.htm

http://www.mayoclinic.com/health/saw-palmetto/NS_patient-sawpalmetto

Treben M. Zdravlje iz Božje ljekarne. Savjeti i iskustva u liječenju ljekovitim biljem. Mozaik knjiga Zagreb, 2004.

Literatura